THC Global Group Limited (THC Global or the Company) (ASX:THC) (OTCMKTS:HDRPF) provides, in accordance with Listing Rule 3.17.1, a copy of the April 2019 Briefing Note which has been sent to shareholders of the Company today.

To view the Briefing Note, please visit:
http://abnnewswire.net/lnk/161O54I5


About THC Global Group Limited

THC Global Group Limited (ASX:THC) (OTCMKTS:HDRPF) (FRA:9TH) operates under a 'Farm to Pharma' pharmaceutical model, now holding all three key cannabis licences being a Cannabis Research Licence, a Medicinal Cannabis Licence (Cultivation), and a Manufacture Licence through its domestic medicinal cannabis subsidiaries THC Pharma and Canndeo. THC Global has secured a significant cannabis growing capacity over multiple cultivation projects and owns a pharmaceuticals bio-manufacturing facility with attached testing and product development laboratory. THC Global is in prime position to commence medicinal cannabis production to service both domestic patients and the global export market. THC Global is active globally with operations in Australia, New Zealand, and Canada and partnerships across Europe, Asia, and the Middle East. In addition to its core Australian medicinal cannabis assets, THC Global has a significant Canadian presence – both in cannabis and in hydroponics equipment. THC Global's Canadian cannabis operation, Vertical Canna, holds property in Nova Scotia, Canada being developed into a large scale cannabis production site. THC Global's hydroponics equipment division, Crystal Mountain, is a revenue generating manufacturer, wholesaler, and retailer of hydroponic equipment and supplies.

    

Contact

Ken Charteris
Chief Executive Officer
e: corporate@thc.global

Henry Kinstlinger
Company Secretary
e: corporate@thc.global
p: +61-2-8644-0601

Sonny Didugu
Investor & Media
e: media@thc.global
p: +61-2-8088-4760



Link: THC Global April 2019 Briefing Note


Related Companies

THC Global Group Limited


Related Industry Topics: